Almirall, S.a.
Clinical trials sponsored by Almirall, S.a., explained in plain language.
-
New hope for painful skin condition: experimental drug LAD328 enters phase 2 trial
Disease control Not yet recruitingThis study tests an experimental drug called LAD328 against a placebo in 50 adults with moderate-to-severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. The goal is to see if LAD328 can reduce the number of inflamed lesions and improve symptoms. Partic…
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated May 26, 2026 11:39 UTC
-
New hope for stubborn Coin-Shaped eczema: drug trial launches
Disease control Not yet recruitingThis study tests a new drug called lebrikizumab for adults with nummular eczema (coin-shaped patches) that doesn't get better with steroid creams or when those creams aren't safe to use. About 270 adults will receive either the drug or a placebo. The main goal is to see if the dr…
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC